LDRS:NYE-Innovator IBD ETF Leaders ETF

ETF | Others |

Last Closing

USD 21.86

Change

-0.06 (-0.28)%

Market Cap

USD 0.02B

Volume

1.80K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-10-18 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE SOJE

+0.20 (+1.06%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

+0.47 (+0.85%)

USD 32.43B
DTB DTB

+0.30 (+1.58%)

USD 26.58B
DFAC Dimensional U.S. Core Equity 2..

+0.28 (+0.93%)

USD 26.00B
GBTC Grayscale Bitcoin Trust (BTC)

+1.95 (+3.40%)

USD 23.75B
JPST JPMorgan Ultra-Short Income ET..

+0.02 (+0.04%)

USD 22.73B
SGOV iShares® 0-3 Month Treasury B..

+0.01 (+0.01%)

USD 19.79B
AVUV Avantis® U.S. Small Cap Value..

+0.82 (+0.93%)

USD 10.49B
DFUV Dimensional US Marketwide Valu..

+0.32 (+0.82%)

USD 10.15B
DFAT Dimensional U.S. Targeted Valu..

+0.59 (+1.16%)

USD 9.40B

ETFs Containing LDRS

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.25% 21% F 27% F
Dividend Return 0.70% 17% F 11% F
Total Return 2.94% 20% F 25% F
Trailing 12 Months  
Capital Gain -6.31% 19% F 30% F
Dividend Return 1.03% 23% F 16% F
Total Return -5.28% 18% F 28% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A F
Dividend Return N/A N/A N/A N/A F
Total Return N/A N/A N/A N/A F
Average Annual (5 Year Horizon)  
Capital Gain -6.76% 9% A- 16% F
Dividend Return -6.41% 9% A- 13% F
Total Return 0.35% 14% F 9% A-
Risk Return Profile  
Volatility (Standard Deviation) 7.99% 65% D 80% B-
Risk Adjusted Return -80.22% 5% F 5% F
Market Capitalization 0.02B 24% F 10% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.